Class IITerminatedD-0633-2018
Drug recall · April 25, 2018
Amantadine HCl Capsules recall
Why: Failed Dissolution Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15
- Lots / codes
Lot: 16719 Exp. 07/2018
- Quantity
- 2135 cartons
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide
- Initiated
- March 30, 2018 · Voluntary: Firm initiated
- Classified
- April 17, 2018
- Reported
- April 25, 2018
- Ended
- June 4, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amantadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.